
Drug Development
Special Challenges in Pediatric Drug Development: First of Three Sets of Expanded Proceedings from the ISCTM Autumn Conference on Pediatric Drug Development
by Philip D. Harvey, PhD; Joan Busner, PhD; Gahan Pandina,
by Philip D. Harvey, PhD; Joan Busner, PhD; Gahan Pandina,
by Gahan Pandina, PhD; Joan Busner, PhD; Joseph P. Horrigan,
by Joan Busner, PhD; Gahan Pandina, PhD; Simon Day, PhD; Atul
by Holly Posner, MD, MS; Rosie Curiel, PsyD; Chris Edgar,
Innov Clin Neurosci. 2017;14(1–2)3–23. A MESSAGE FROM THE EDITOR Dear
by the CNS SUMMIT DATA QUALITY MONITORING WORKGROUP CORE MEMBERS—David
by Jared W. Young, PhD; William Z. Potter, MD, PhD;
by Steven T. Szabo, MD, PhD; Bruce J. Kinon, MD;
by Harald Murck, MD, PhD; Thomas Laughren, MD; Femke Lamers,
by Joanne B. Severe, MS, and Annette Stemhagen, DrPH, FISPE